Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis.
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis.
复制标题
DOI:
10.1053/j.ajkd.2008.11.034
复制
发表时间:
2009-06
期刊:
影响因子:
--
通讯作者:
Parikh CR
中科院分区:
文献类型:
--
作者:
Coca SG;Yusuf B;Shlipak MG;Garg AX;Parikh CR
Acute kidney injury (AKI) is common in hospitalized patients. The impact of AKI on long-term outcomes is controversial. Systematic review and meta-analysis. Persons with AKI. MEDLINE and EMBASE databases were searched from 1985 through October 2007. Original studies describing outcomes of AKI for patients who survived hospital discharge were included. Studies were excluded from review when participants were followed for < 6 months. AKI, as defined by acute changes in serum creatinine or acute need for renal replacement therapy. CKD, cardiovascular disease, mortality. Forty nine studies that contained a total of 47,017 participants were reviewed. Fifteen of these studies reported long-term data for patients without AKI. The incidence rate of mortality was 8.9 per 100 person-years in survivors of AKI and was 4.3 per 100 patient-years in survivors without AKI (RR 2.59, 95% CI 1.97-3.42). AKI was associated independently with mortality risk in 6 of 6 studies that performed multivariate adjustment (adjusted RR 1.6-3.9) and it was associated with myocardial infarction in 2 of 2 studies (RR 2.05, 95% CI 1.61-2.61). The incidence rate of CKD after an episode of AKI was 7.8 per 100 patient years and the rate of ESRD was 4.9 per 100 patient-years. The relative risk for CKD and ESRD after AKI was unattainable due to lack of follow-up of appropriate non-AKI controls. The development of AKI, as defined by acute changes in serum creatinine characterizes hospitalized patients at elevated risk of long-term adverse outcomes.
登录
查看更多内容
影响因子:
13.2
作者:
Abosaif, NY;Tolba, YA;El Nahas, AM
通讯作者:
El Nahas, AM
影响因子:
38.9
作者:
de Mendonça, A;Vincent, JL;Cantraine, F
通讯作者:
Cantraine, F
影响因子:
13.2
作者:
Coca, Steven G.;Peixoto, Aldo J.;Parikh, Chirag R.
通讯作者:
Parikh, Chirag R.
DOI:
10.1016/0197-2456(86)90046-2
发表时间:
1986-09-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
DERSIMONIAN, R;LAIRD, N
通讯作者:
LAIRD, N
影响因子:
13.2
作者:
Bagshaw, Sean M.;Mortis, Garth;Laupland, Kevin B.
通讯作者:
Laupland, Kevin B.